UNITED SERVICES AUTOMOBILE ASSOCIATION - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
UNITED SERVICES AUTOMOBILE ASSOCIATION ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$1,028,000
+2.4%
394,037
+0.9%
0.00%0.0%
Q1 2019$1,004,000
+11.8%
390,5920.0%0.00%0.0%
Q4 2018$898,000
-28.4%
390,5920.0%0.00%0.0%
Q3 2018$1,254,000
+11.9%
390,592
-1.4%
0.00%0.0%
Q2 2018$1,121,000
-16.7%
396,267
+4.3%
0.00%
-25.0%
Q1 2018$1,345,000
-2.7%
379,867
+6.6%
0.00%0.0%
Q4 2017$1,383,000
+64.4%
356,472
+7.6%
0.00%
+100.0%
Q3 2017$841,000
-4.6%
331,180
+2.5%
0.00%
-33.3%
Q2 2017$882,000
-13.7%
323,020
+4.6%
0.00%0.0%
Q1 2017$1,022,000
+33.8%
308,695
-3.8%
0.00%0.0%
Q4 2016$764,000
+54.7%
321,040
+138.5%
0.00%
+50.0%
Q3 2016$494,000
+64.1%
134,600
-0.2%
0.00%
+100.0%
Q2 2016$301,000
+4.2%
134,930
-2.7%
0.00%0.0%
Q1 2016$289,000
-29.2%
138,730
+3.1%
0.00%0.0%
Q4 2015$408,000
+24.4%
134,530
+1.3%
0.00%0.0%
Q3 2015$328,000
-26.6%
132,770
-4.6%
0.00%
-50.0%
Q2 2015$447,000
-8.2%
139,210
+2.0%
0.00%0.0%
Q1 2015$487,000
+66.8%
136,510
+6.1%
0.00%
+100.0%
Q4 2014$292,000
+22.7%
128,630
+4.8%
0.00%0.0%
Q3 2014$238,000
-46.5%
122,7000.0%0.00%
-50.0%
Q2 2014$445,000
-5.5%
122,700
+1.1%
0.00%0.0%
Q1 2014$471,000
+36.1%
121,4000.0%0.00%
+100.0%
Q4 2013$346,000
-20.5%
121,4000.0%0.00%
-50.0%
Q3 2013$435,000
+7.4%
121,4000.0%0.00%0.0%
Q2 2013$405,000121,4000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders